Cooperative Agreement DENA0003922

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,231,201.00 to the University of Wisconsin - Madison to develop novel PET/CT radiotracers to identify high-risk clear cell renal cell carcinoma patients. The award has a performance period from August 1, 2025 to July 31, 2028. The project aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...

This federal Project Grant award of $1,600,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by Northwestern University to potentiate long-lived antitumor effector CD8+ T cells for triple-negative breast cancer (TNBC) therapy. The award will fund research over a period of approximately 3 years, from December 2024 to December 2027, to investigate innovative approaches to enhance the function and...

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $640,000.00 to Northwestern University to enhance bispecific antibody therapy with nanoparticle-based photothermal therapy. The award period runs from August 15, 2024 to August 14, 2026. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Northwestern University, a...

This Cooperative Agreement award of $999,545.00 from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program aims to complete engineering and validation activities for a novel minimally invasive cryoablation probe and external cryogenic agent controller system. The goal is to develop an adjunctive thermal therapy that can be performed by breast cancer surgeons immediately following a lumpectomy to reduce or eliminate remaining...

This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $234,000.00 to the University of Texas at Dallas (UTD) to conduct in vivo hyperpolarized MRI research on abnormal metabolism in prostate cancer. The award period runs from September 1, 2025 to August 31, 2027. UTD, a prominent public research university, will leverage its expertise in biomedical research, materials science, and advanced technology development to...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to M3D, Inc. will develop a novel gamma-ray radiation imager for image-guided tumor diagnostics. The goal is to create a system capable of rapidly and accurately detecting gamma-ray emitting radiotracers used to identify the location of lymph nodes and tumor drainage during cancer surgical procedures. The project will characterize the design parameters of the...

This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...

This federal Project Grant award, valued at $3,618,191.00 and issued on July 1, 2024, is funded by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The award supports the development of a portable hemodialysis device to facilitate home use and field implementation. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will lead the research and development efforts. This includes optimizing a...

This STTR Phase I project, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to advance the development and evaluation of a hand-held induction heater device for treating pancreatic and prostate cancer using magnetic fluid hyperthermia (MFH) technology. The project, awarded to Ihnnova LLC, a small business located in Guánica, Puerto Rico, will receive $275,000 in funding over the period of October 1, 2024 to...

The Project Grant award of $1,396,588.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports the construction and testing of a novel combined magnetic resonance imaging (MRI) and transcranial magnetic stimulation (TMS) device optimized for the treatment of sensory dysfunction after traumatic brain injury. The awardee, Weinberg Medical Physics, Inc., is a for-profit organization that specializes in...